Overview

A Study to Evaluate the Effect of Romosozumab (AMG 785) on Bone Quality of the Forearm in Postmenopausal Women With Low Bone Mass

Status:
Completed
Trial end date:
2010-08-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of romosozumab on parameters of bone quality of the forearm using peripheral quantitative computed tomography (pQCT) following multiple subcutaneous dose administrations of romosozumab in postmenopausal women with low bone mass.
Phase:
Phase 1
Details
Lead Sponsor:
Amgen